
|
Report Date : |
16.01.2007 |
IDENTIFICATION DETAILS
|
Name : |
INTERMED JAPAN INC |
|
|
|
|
Registered Office : |
SC
Sakaisuji Honmachi Bldg 9F, 1-4-15 Kitakyuhojimachi Chuoku |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
Oct 1980 |
|
|
|
|
Legal Form : |
Limited Company (Kabushiki
Kaisha) |
|
|
|
|
Line of Business : |
Import and wholesale of medical
instruments |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
Maximum Credit Limit : |
Yen
141.3 millions |
|
|
|
|
Status : |
Satisfactory
|
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
name
INTERMED JAPAN INC
REGD NAME
KK Intermed
MAIN OFFICE
SC Sakaisuji Honmachi Bldg 9F,
1-4-15 Kitakyuhojimachi Chuoku
Tel : 06-6262-2481
Fax : 06-6262-7556
*.. See REGISTRATION for subsidiary JSS Inc
URL : http://www.intermedjp.co.jp
E-Mail address: info@intermedjp.co.jp
ACTIVITIES
Import, wholesale of medical
instruments
LICENSES
Medical Instruments Importer / distributor’s
License : No. 27BY5059 since 01/Dec/1983; Medical Instruments Mfg License: No.
33BZ5002 since 12/Dec/1988; granted from the Ministry of Health,
BRANCHES
FACTORY(IES)
Katsuta (Okayama-Pref): mfg, storing, warehousing, tests & inspection, quality control, sterilizing, packing, repairing, etc.
OFFICERS
KEN’ICHI KANEMARU, PRES Yutaka Ono, s/mgn dir
Keiji Omata, mgn dir Yoshitaka Hattori,
dir
Mariko
Yen Amount: In million Yen, unless otherwise stated
SUMMARY
FINANCES FAIR A/SALES Yen 3,300 M
PAYMENTS REGULAR CAPITAL Yen 30 M
TREND STEADY WORTH Yen 2,700 M
STARTED 1980 EMPLOYES 113
COMMENT
IMPORTER AND WHOLESALER OF MEDICAL INSTRUMENTS. FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY BUSINESS ENGAGEMENTS.
MAX CREDIT LIMIT: YEN 141.3 MILLION, 30 DAYS NORMAL TERMS.
HIGHLIGHTS
The subject company was established by
Ken’ichi Kanemaru for importing medical equipment from
FINANCIAL INFORMATION
The sales volume for Oct/2005 fiscal term amounted to Yen 3,300 million, a 10% up from Yen 3,000 million in the previous term. This was thanks to increased demand for cardiac surgery-related equipment and apparatus. The net profit was posted at Yen 150 million, up 15% from Yen 130 million a year ago.
For the term ended Oct 2006 the net profit is thought posted at Yen 160 million, on a 6% rise in turnover, to Yen 3,500 million. Final results have not been made available.
The financial situation is considered FAIR and good for ORDINARY business engagements. Max credit limit is estimated at Yen 141.3 million, on 30 days normal terms.
REGISTRATION
Date Registered: Oct 1980
Legal Status: Limited
Company (Kabushiki Kaisha)
Authorized: 240,000
shares
Issued: 60,000
shares
Sum: Yen
30 million
Major shareholders (%): Ken’ichi Kanemaru (52)
No. of shareholders: 8
Nothing detrimental is known as
to the commercial morality of executives.
*.. JSS Inc, at 8F of the caption address, separated from the subject firm in May/1991 to focus on import and wholesale of surgical medical instruments from V Mueller, USA; Medical Instruments Importer/Distributor’s License: 27B1X00040 granted from the Minister of Health, Labor and Welfare. Management & operations, including domestic & overseas branch offices, are fully integrated with the parent, Intermed Japan Inc.
URL: http://jss.co.jp (Japanese only)
OPERATION
Activities: Imports and wholesales medical equipment, apparatus, supplies (--100%); such as: Operating room products (gloves/non-woven), patient care products, respiratory care products, surgical instruments, ligation systems, medical instruments, electric surgical generation, feeding rubes/disposable catheters, minimum invasive surgery products (MIS), surgical light sources, surgical visual system, Cosgrove, endoscope, others
Clients: [Mfrs, wholesalers, hospitals] Nipro, Mutow Co, JSS Inc, Yagami Co, Hama Medical Ind, Kishiya, Masuda Ika Kikai, Towa Ika Kikai, other.
No. of accounts: 500
Domestic areas of activities:
Nationwide
Suppliers: [Mfrs, wholesalers] Timesco, EMS, Unomidical, Hudson RCI, V Mueller, Ansell Healthcare, ConMed Corp, AcuLux, Teleflex, Access Surgical, CV Medica, Bissinger, Nashville Surgical Instruments, Conform, other from USA, Europe, etc.
Payment record: Regular
Location: Business area in
Bank References
Chugoku Bank (
Mizuho Bank (Osaka-Chuo)
Relations: Satisfactory
FINANCES
(In Million Yen)
|
Terms Ending: |
31/10/2006 |
31/10/2005 |
31/10/2004 |
31/10/2003 |
|
|
Annual
Sales |
|
3,500
|
3,300
|
3,000
|
3,150
|
|
Recur.
Profit |
(*) |
|
625 |
210 |
|
|
Net
Profit |
|
160 |
150 |
130 |
101 |
|
Total
Assets |
|
|
3,900
|
|
3,210
|
|
Current
Assets |
|
|
2,550
|
|
2,250
|
|
Current
Liabs |
|
|
910 |
|
710 |
|
Net
Worth |
|
|
2,700
|
|
2,500
|
|
Capital,
Paid-Up |
|
|
30 |
30 |
30 |
|
<Analytical
Data> |
(%) |
(%) |
(%) |
(%) |
|
|
S.Growth Rate |
6.06 |
10.00
|
-4.76
|
5.07 |
|
|
Current Ratio |
|
.. |
280.22
|
.. |
316.90
|
|
N.Worth Ratio |
.. |
69.23
|
.. |
77.88
|
|
|
R.Profit/Sales |
|
.. |
.. |
.. |
13.65
|
|
N.Profit/Sales |
4.57 |
4.55 |
4.33 |
3.21 |
|
|
Return On Equity |
.. |
5.56 |
.. |
4.04 |
|
Note: Financials are disclosed only in rounded-off figures. B/S’s are disclosed for the 31/10/2005 & 31/10/2003 fiscal terms only.
Forecast (or estimated) for the
31/10/2006 fiscal term.
(*) Pretax profits disclosed from
the Taxation Office.
|
Terms Ending: |
31/10/2006 |
31/10/2005 |
31/10/2004 |
31/10/2003 |
|
|
Annual Sales |
|
3,500 |
3,300 |
3,000 |
3,150 |
|
Recur. Profit |
|
|
|
|
430 |
|
Net Profit |
|
160 |
150 |
130 |
101 |
|
Total Assets |
|
|
3,900 |
|
3,210 |
|
Current Assets |
|
|
2,550 |
|
2,250 |
|
Current Liabs |
|
|
910 |
|
710 |
|
Net Worth |
|
|
2,700 |
|
2,500 |
|
Capital, Paid-Up |
|
|
30 |
30 |
30 |
|
<Analytical
Data> |
(%) |
(%) |
(%) |
(%) |
|
|
S.Growth Rate |
6.06 |
10.00 |
-4.76 |
5.07 |
|
|
Current Ratio |
|
.. |
280.22 |
.. |
316.90 |
|
N.Worth Ratio |
.. |
69.23 |
.. |
77.88 |
|
|
R.Profit/Sales |
|
.. |
.. |
.. |
13.65 |
|
N.Profit/Sales |
4.57 |
4.55 |
4.33 |
3.21 |
|
|
Return On Equity |
.. |
5.56 |
.. |
4.04 |
|
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial
base with the strongest capability for timely payment of interest and
principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No
caution needed for credit transaction. It has above average (strong)
capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are
regarded healthy. General unfavourable factors will not cause fatal effect.
Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors
carry similar weight in credit consideration. Capability to overcome
financial difficulties seems comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of
interest and principal sums in default or expected to be in default upon
maturity |
Limited with full security |
|
<10 |
C |
Absolute credit risk exists. Caution
needed to be exercised |
Credit not recommended |
|
NR |
In view of the lack of information, we
have no basis upon which to recommend credit dealings |
No Rating |
|